Molecular mechanism of activation of endothelial cells involved in early stage of atherosclerosis formation.
内皮细胞活化参与动脉粥样硬化形成早期的分子机制。
基本信息
- 批准号:11307018
- 负责人:
- 金额:$ 23.55万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A).
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have studied Molecular mechanism of activation of endothelial cells involved in early stage of atherosclerosis formation and obtained following results.(1) Oxidization of low density lipoprotein (LDL) has been demonstrated in atherosclerossis formation by laboratories around the world including us. We have found existence of its soluble form of LOX-1, which we had identified as a oxidized LDL receptor on endothelial cells. We also found the mechanism of glycation of LOX-1 and demonstrated the importance of the glycation in the LOX function.(2) Lysophosphatidylcholine (LPC) which was produced during the process of LDL oxidization enhanced expression of several genes involved in atherosclerosis formation via Egf-1 expression.(3) We identified a novle oxidized LDL receptor named SR-PSOX.We found expression of the molecule in the atheromatous plaque and demonstrated the importance in binding of rod-shaped bacteria to endothelial cells.(4) For the formation of atherosclerosis, migration of macrophages has been shown to play a critical role. We found that a chemoattractant factor, MCP-1, employs distinct pathways of intracellular signaling for cell-attachment and migration.(5) The last step of the atherosclerosis is thrombosis formation which is triggered by platelet activation. We found that JAM, junctional adhesion molecule which we identified recently, was also expressed in platelets and phosphorylated upon platelet activation. Furthermore, we have established a semi-intact system for platelet aggregation and granule secretion. We demonstrated that thje involvement of small GTPase Rho in aggregation and Rab4 in a-granule secretion.These results were presented in many international scientific meeting such as the International Atherosclerosis Meeting, European Life Science Meeting, and American Heart Association Meeting.
我们已经研究了参与动脉粥样硬化形成早期的内皮细胞激活的分子机制,并在结果之后获得了。(1)在世界各地的实验室中,在包括我们在内的世界各地的实验室中都证明了低密度脂蛋白(LDL)的氧化。我们发现其可溶性的LOX-1形式存在,我们在内皮细胞上已将其确定为氧化的LDL受体。我们还发现了LOX-1糖基化的机制,并证明了糖化在LOX功能中的重要性。(2)在LDL氧化过程中产生的溶物磷脂酰胆碱(LPC),这是在LDL氧化过程中产生的,增强了几种基因表达的表达,涉及通过EGF-1表达的动脉粥样硬化形成的几个基因。动脉瘤斑块中的分子,证明了棒形细菌与内皮细胞结合的重要性。(4)对于动脉粥样硬化的形成,巨噬细胞的迁移已显示出至关重要的作用。我们发现,趋化因子MCP-1采用细胞内信号传导的不同途径进行细胞跟踪和迁移。(5)动脉粥样硬化的最后一步是血栓形成,是由血小板激活触发的。我们发现,我们最近确定的果酱,连接粘附分子也在血小板中表达,并在血小板激活后磷酸化。此外,我们已经建立了一个半完整的血小板聚集和颗粒分泌系统。我们证明了小型GTPase Rho在Aggregation和Rab4中的参与。
项目成果
期刊论文数量(47)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kataoka H.,Kume N.,Miyamoto S.et al.: "Biosynthesis and Post-translational processing of Lectin-like Oxidized low density lipoprotein Receptor-1 (Lox-1)"The Journal of Biological chemistry. 275(9). 6573-6579 (2000)
Kataoka H.,Kume N.,Miyamoto S.et al.:“凝集素样氧化低密度脂蛋白受体-1(Lox-1)的生物合成和翻译后加工”生物化学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kataoka, H., Yokode, M., Murayama, T., Mori, S., Ozaki, H., Sano, H., Yokota, Y., Nishikawa, S.-I., Kita, T.: "Novel Snail-related zinc finger transcription factor Smuc regulates the activities of basic helix-loop-helix transcription factors."Nucl.Acid Re
片冈 H.、横出 M.、村山 T.、森 S.、尾崎 H.、佐野 H.、横田 Y.、西川 S.-I.、北 T.:“小说
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shirakawa,R.,Yoshioka,A., et al.: "Small GTPase Rab4 Regulates Ca2+-induced α-Granule Secretion in Platelets."Journal of Biological Chemistry. 275. 33844-33849 (2000)
Shirakawa, R.、Yoshioka, A. 等人:“小 GTP 酶 Rab4 调节血小板中 Ca2+ 诱导的 α-颗粒分泌”。生物化学杂志 275. 33844-33849 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shimaoka, T., Kume, N., Minami, M., Hayashida, K., Kataoka, H., Kita, T., Yonehara, S.: "Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages."J.Biol.Chem.. 275. 40663-40666 (2000)
Shimaoka, T.、Kume, N.、Minami, M.、Hayashida, K.、Kataoka, H.、Kita, T.、Yonehara, S.:“氧化低密度脂蛋白 SR 的新型清道夫受体的分子克隆
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kataoka H.,Kume N.,Miyamoto T.et al.: "Expression of lectin-like oxidized LDL receptor-1 in human atherosclerotic lesions"Circulation. 99(24). 3110-3117 (1999)
Kataoka H.,Kume N.,Miyamoto T.et al.:“人类动脉粥样硬化病变中凝集素样氧化LDL受体1的表达”循环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KITA Toru其他文献
KITA Toru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KITA Toru', 18)}}的其他基金
Molecular mechanism of the process from atherosclerotic lesion formation to plaque rupture
动脉粥样硬化病变形成到斑块破裂过程的分子机制
- 批准号:
16209031 - 财政年份:2004
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Cell biological study for atherosclerosis
动脉粥样硬化的细胞生物学研究
- 批准号:
11694266 - 财政年份:1999
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
Molecular Mechanism of Atherosclerosis
动脉粥样硬化的分子机制
- 批准号:
09281103 - 财政年份:1997
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)
動脈硬化の分子機構
动脉硬化的分子机制
- 批准号:
09281104 - 财政年份:1997
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)
Molecular mechanism on the progression of atherosclerosis.
动脉粥样硬化进展的分子机制。
- 批准号:
07044255 - 财政年份:1995
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for international Scientific Research
Development of new drug for intractable hyperlipidemia and its clinical application
顽固性高脂血症新药的研制及其临床应用
- 批准号:
07557073 - 财政年份:1995
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Studies on the initiation and regression of atherosclerosis
动脉粥样硬化发生和消退的研究
- 批准号:
05044163 - 财政年份:1993
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for international Scientific Research
Gene engineering, cell biological aproaches to the mechanisms for early stage of atherosclerosis
基因工程、细胞生物学方法研究动脉粥样硬化早期的机制
- 批准号:
05404039 - 财政年份:1993
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for General Scientific Research (A)
Development and clinical application of novel anti-atherogenic drug.
新型抗动脉粥样硬化药物的开发及临床应用。
- 批准号:
05557052 - 财政年份:1993
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Establishment of a new antiatherosclerotic drug and its screening methods using an animal model.
抗动脉粥样硬化新药的建立及其动物模型筛选方法
- 批准号:
03557116 - 财政年份:1991
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
相似国自然基金
基于“脾统血濡脉”探讨健脾益气法调控LOX-1/SPP1/EGF通路驱动mtROS 预防AS分子机制研究
- 批准号:82305061
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于NASH类器官模型的SQLE/Nrf2/LOX-1轴在动脉粥样硬化斑块形成与稳定性中的作用及机制研究
- 批准号:82370517
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
LOX-1介导脂质沉积在低氧肺动脉高压右心室重构中的作用及机制
- 批准号:82241025
- 批准年份:2022
- 资助金额:50.00 万元
- 项目类别:专项项目
LOX-1介导种植体周围炎炎性骨吸收的机制研究
- 批准号:82201107
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
LOX-1介导种植体周围炎炎性骨吸收的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
新生児低酸素性虚血性脳症における、LOX-1をターゲットとした新規治療法の開発
开发针对新生儿缺氧缺血性脑病的LOX-1新疗法
- 批准号:
24K18861 - 财政年份:2024
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Cell-free hemoglobin-oxidized LDL-LOX-1 axis and microvascular hyperpermeability during sepsis
脓毒症期间无细胞血红蛋白氧化的 LDL-LOX-1 轴和微血管通透性过高
- 批准号:
10739620 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Targeting LOX-1 for MDSC-inhibition therapy against cervical cancer
以 LOX-1 为靶点进行 MDSC 抑制治疗宫颈癌
- 批准号:
23K06666 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
LOX-1 as a protective countermeasure in response to lung infection
LOX-1 作为应对肺部感染的保护性对策
- 批准号:
10677924 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Resolution of inflammation and atrial fibrillation
炎症和心房颤动的解决
- 批准号:
10679718 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别: